key: cord-0954663-jwbsznu2
authors: Sutton, Nadia R.; Kawamoto, Kris R.
title: Lessons Learned From the MERS-CoV Outbreak
date: 2020-12-04
journal: Cardiovasc Revasc Med
DOI: 10.1016/j.carrev.2020.12.007
sha: e755fff47c371520a680d63472f236dc05f8de35
doc_id: 954663
cord_uid: jwbsznu2

nan

The Coronavirus 2019 pandemic is not the first, nor will it be the last, infectious disease outbreak that the world will experience. COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is responsible for over a million deaths worldwide [1] . Two previously identified coronaviruses, SARS-CoV and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), have been responsible for outbreaks of severe respiratory illness in the recent past. The 2003 SARS outbreak was associated with greater than 8000 reported cases and more than 700 deaths, with a case fatality rate of 9.7% [2] . The MERS-CoV outbreak emerged in 2012 and resulted in greater than 2000 reported cases and more than 800 deaths in 27 countries and was associated with a very high case fatality rate (34%) [2] . In light of the ongoing COVID-19 pandemic, it bears repeating the old adage that those that fail to learn from history are doomed to repeat it. In the case of the MERS-CoV outbreak, health systems identified strategies to manage cardiovascular care in spite of the public health crisis. More recently, governmental and regulatory bodies and health systems needed to quickly adopt similar strategies for management of patients with acute cardiovascular events during the COVID-19 pandemic.

In this issue of the journal, Alasnag et al. [3] present a retrospective, observational study of patients who were admitted to a single center in Saudi Arabia for acute coronary masks. In this study, all patients with STEMI met the guideline recommendation of a door-to-balloon time of less than 90 minutes [4] . Patients with an NSTEMI were stratified into high-and low-risk groups based on their Global Registry of Acute Coronary Event (GRACE) score [3] . Patients with a GRACE score > 140 were designated as high-risk and were assigned to an early invasive strategy (within 24 hours), regardless of their MERS-CoV status. Patients with a low-risk NSTEMI underwent MERS-CoV screening before the treatment strategy was determined. Lowrisk patients with negative screening tests were treated with an invasive strategy once their test results returned, and those who were positive were treated conservatively.

It is commendable that there was no transmission of MERS-CoV to staff (nurses, physicians, radiographers, cardiovascular technologists) directly involved in patient care in this study. Although MERS-CoV is significantly less infectious compared to 6] , wearing appropriate PPE and overall low healthcare worker exposure were important factors in mitigating the spread of infection. The authors state that a key component of providing expeditious cardiac care and maintaining low infectivity depended on consolidating the care of infected patients to a subset of medical centers.

In Saudi Arabia during the MERS-CoV outbreak, the Ministry of Heath (MOH) designated specific hospitals to care for patients with confirmed infection so that other tertiary care centers could maintain a low admission rate of infected cases [3] . This strategy may not be easily adopted in other areas of the world during a viral pandemic.

For example, some countries (such as the United States) do not have a national health care system, and a high volume of infected patients could make it difficult to isolate these patients to a limited number of hospitals.

Another important finding in this study was the significantly lower than usual number of patients who presented to the hospital with ACS. A reduction in patients presenting to hospitals with ACS during the COVID pandemic has also been reported [7, 8] . The notable decrease in the number of patients presenting with ACS during the pandemic has been ascribed to patients' concerns of contracting a serious infection in the hospital [3, 7] . Despite consolidating MERS-CoV care in other hospitals, the tertiary cardiovascular center in this study reported an approximately 70% reduction in all ACS admissions [3] . This highlights the importance of (1) ensuring that health care systems are equipped to continue managing acute cardiovascular events in the midst of another public health crisis and (2) a need for a strong message to the public to continue to seek care for new cardiovascular symptoms. We cannot apply guideline-directed therapy unless patients seek care; late presentation impacts short-and long-term clinical outcomes.

Medicine Coronavirus Resource Center

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics

Management of acute coronary syndrome during the MERS-CoV outbreak -Single center experience

ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart 6

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard

Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic

pandemic and admission rates for and management of acute coronary syndromes in England

Catheterization Laboratory Considerations During the Coronavirus (COVID-19)

Pandemic: From the ACC's Interventional Council and SCAI